Please login to the form below

Not currently logged in
Email:
Password:

Chiesi Global Rare Diseases

This page shows the latest Chiesi Global Rare Diseases news and features for those working in and with pharma, biotech and healthcare.

Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease

Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease

Protalix Biotherapeutics and Chiesi Global Rare Diseases’s monthly treatment PRX-102 has demonstrated positive top-line results in a phase 3 trial evaluating the therapy in Fabry disease. ... On behalf of our team at Chiesi, we are grateful to the

Latest news

  • Chiesi launches new rare disease R&D division Chiesi launches new rare disease R&D division

    The new business unit – Chiesi Global Rare Diseases – will be headquartered in Boston, US and will have an initial focus on research and product development in lysosomal storage disorders, rare haematology ... With the Chiesi Global Rare Diseases unit

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics